Hanseatic Management Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-386
Closed -$20K 146
2022
Q1
$20K Hold
386
0.03% 93
2021
Q4
$23K Buy
+386
New +$19.1K 0.04% 90
2019
Q2
Sell
-3,673
Closed -$148K 258
2019
Q1
$148K Buy
3,673
+672
+22% +$26.9K 0.15% 128
2018
Q4
$124K Buy
3,001
+534
+22% +$22.2K 0.17% 113
2018
Q3
$103K Buy
+2,467
New +$95K 0.1% 138
2015
Q4
Sell
-11,922
Closed -$355K 365
2015
Q3
$355K Sell
11,922
-333
-3% -$10.7K 0.11% 196
2015
Q2
$390K Sell
12,255
-4,201
-26% -$137K 0.17% 160
2015
Q1
$543K Buy
+16,456
New +$523K 0.29% 94

Other funds holding PFE

Hanseatic Management Services's PFE Position: Q2 2022 in Review

Hanseatic Management Services sold out of Pfizer (PFE) in Q2 2022, closing a stake of 386 shares — an estimated $20K sold.

Hanseatic Management Services first reported a position in PFE in Q1 2015 and held it in 8 quarters. The position peaked at $543K in Q1 2015. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Hanseatic Management Services reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 386 Pfizer shares in Q2 2022, an estimated $20K.
  • Hanseatic Management Services first reported a position in Pfizer in Q1 2015 and held it in 8 quarters.
  • Hanseatic Management Services's Pfizer position peaked at $543K in Q1 2015.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Hanseatic Management Services's 13F filing for Q2 2022, filed 5 Aug 2022.